Dianthus Therapeutics, Inc. /DE/ (DNTH)

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Address

300 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139

Founded

2015

Number of Employees

53

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)